Feed

Case Study: US Equity Option Market Makers – Core Strategies and Market Shares, 2019-2023

In this 187-page, 213-exhibit, 45,000-word case study, “US Equity Option Market Makers: Core Strategies and Market Shares, 2019 – 2023,” Alphacution publishes its most comprehensive analysis to date based on the modeling of 17 proprietary trading firms who serve variously as market makers in US equity derivatives across the backdrop of 5 interconnected product classes in futures and options. The objective of this research project was to shed new light on US equity option market mechanics by exploring the products,...

US Equity Options: The Money Shot Teasers

Against the rapidly evolving composition of products and customers in the US equity option market during a 5-year focus period, 2019 - 2023, Alphacution assembled, normalized, and integrated several publicly-available datasets to take the unprecedented step of modeling and analyzing a group of 17 proprietary trading firms – all of which are registered broker-dealers trading securities for their own account – individually and as a group… In this Feed post, Alphacution presents a few "teasers" from its upcoming case study...

Estimating The Shorts Universe

Alphacution expands on the introduction of its Strategy Factor Library with a deeper dive into its method for estimating the potential universe of short stock and short ETF securities as a component of the core trading strategy for a large group of option market makers...

Introducing Alphacution’s Strategy Factor Library

Alphacution goes wider and deeper than ever before - as part of the research for our unexpectedly exhaustive case study on US equity option markets and option market makers - to compare trading entities based on at least 84 strategy factors from the simplest factors - like securities universe or number of positions by product class - to some of the most sophisticated comparisons that Alphacution has ever attempted. In this Feed post, we publish this list - the first...
Receive updates on Alphacution's latest research.